<unk>  is an oligonucleotide mixture with profibrinolytic properties that is FDA approved for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).   Common adverse reactions include hypotension, diarrhea, vomiting, nausea, and epistaxis (≥10%).
Defibrotide
Eptifibatide
Bemiparin
Ticlopidine
Tenecteplase
Ticagrelor
Oxeladin
Iotalamic acid